- Home
- KLRS vs QIPT Comparison
KLRS vs QIPT Comparison
Compare KLRS & QIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- QIPT
- Stock Information
- Founded
- KLRS 2019
- QIPT 1993
- Country
- KLRS United States
- QIPT United States
- Employees
- KLRS N/A
- QIPT 1200
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- QIPT
- Sector
- KLRS Health Care
- QIPT
- Exchange
- KLRS Nasdaq
- QIPT Nasdaq
- Market Cap
- KLRS 129.0M
- QIPT 92.2M
- IPO Year
- KLRS N/A
- QIPT N/A
- Fundamental
- Price
- KLRS $3.89
- QIPT $2.15
- Analyst Decision
- KLRS Buy
- QIPT Strong Buy
- Analyst Count
- KLRS 1
- QIPT 2
- Target Price
- KLRS N/A
- QIPT $6.50
- AVG Volume (30 Days)
- KLRS 62.9K
- QIPT 102.6K
- Earning Date
- KLRS 05-19-2025
- QIPT 05-12-2025
- Dividend Yield
- KLRS N/A
- QIPT N/A
- EPS Growth
- KLRS N/A
- QIPT N/A
- EPS
- KLRS N/A
- QIPT N/A
- Revenue
- KLRS N/A
- QIPT $244,723,000.00
- Revenue This Year
- KLRS N/A
- QIPT $3.35
- Revenue Next Year
- KLRS N/A
- QIPT $5.39
- P/E Ratio
- KLRS N/A
- QIPT N/A
- Revenue Growth
- KLRS N/A
- QIPT 3.82
- 52 Week Low
- KLRS $4.19
- QIPT $1.86
- 52 Week High
- KLRS $24.15
- QIPT $4.17
- Technical
- Relative Strength Index (RSI)
- KLRS N/A
- QIPT 47.85
- Support Level
- KLRS N/A
- QIPT $2.07
- Resistance Level
- KLRS N/A
- QIPT $2.18
- Average True Range (ATR)
- KLRS 0.00
- QIPT 0.07
- MACD
- KLRS 0.00
- QIPT 0.02
- Stochastic Oscillator
- KLRS 0.00
- QIPT 56.86
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing therapeutics. Kalaris is developing TH103, a novel, clinical stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body native, highest affinity VEGF receptor 1.
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.